The Laerdal Million Lives Fund is committed to investing in entrepreneurs who are developing and deploying emerging technologies capable of saving lives across the globe. Our investment thesis aims to contribute to Laerdal’s impact goal of helping save 1 million lives annually by 2030. To achieve this, we prioritize investments that can be globally scalable and meaningful impact mortality rates by improving healthcare access, quality and outcomes to all populations regardless of demographics or geography.

We target investments in commercial-stage companies that address mortality rates across clinical areas, such as maternal, neonatal, emergency medicine, critical care and surgery, and provide better medical education and training to providers and patients. By supporting the companies that are developing innovative and enabling technologies, we hope to play a significant role in reducing mortality across these sectors, which account for over 20 million deaths annually today.